Skip to main content
. 2017 Jul 19;8(35):58847–58864. doi: 10.18632/oncotarget.19375

Figure 9. CIP2A knockdown sensitizes BT474/LR cells to lapatinib-induced inhibition of oncogenic signal transduction.

Figure 9

Control and CIP2A knockdown BT474/LR cells were treated with lapatinib for 16 hours and then analyzed for protein expression using Western blotting.